https://www.scmp.com/news/china/science/article/3036119/china-approves-oligomannate-worlds-first-new-alzheimers-drug-20The development of Oligomannate was inspired by the relatively low occurrence of Alzheimer’s among elderly people who regularly consumed seaweed. The Chinese research team, led by Dr Geng Meiyu at the Chinese Academy of Sciences’ Shanghai Institute of Materia Medica, started looking into possible connections and, in 1997, identified a unique sugar in seaweed which might play an important role in the phenomenon. In September, Geng’s team published a paper announcing a major discovery. They had found that Oligomannat was, in fact, a multitasking agent. It not only reduces the formation of a protein harmful to neurons, but also regulates the bacterium colonies in human intestines to reduce the risk of brain inflammation.
摸 象 或 (不?) 著 木目 於 2019/11/06 00:11回覆
